These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1678201)

  • 1. Murine Trypanosoma cruzi infection: a role for TH2 cells in the immunopathology of chronic infection.
    Hontebeyrie-Joskowicz M
    Res Immunol; 1991 Feb; 142(2):141-3. PubMed ID: 1678201
    [No Abstract]   [Full Text] [Related]  

  • 2. Chagas' disease: CD5 B-cell-dependent Th2 pathology?
    Minoprio P
    Res Immunol; 1991 Feb; 142(2):137-40. PubMed ID: 1714086
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+).
    Ben Younès-Chennoufi A; Said G; Eisen H; Durand A; Hontebeyrie-Joskowicz M
    Trans R Soc Trop Med Hyg; 1988; 82(1):84-9. PubMed ID: 2972093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells.
    Russo M; Starobinas N; Minoprio P; Coutinho A; Hontebeyrie-Joskowicz M
    Ann Inst Pasteur Immunol; 1988; 139(3):225-36. PubMed ID: 2901844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution on the immunopathology of Chagas disease.
    Sadigursky M
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():277-8. PubMed ID: 10677733
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T-cell subpopulations in experimental Chagas' disease.
    Tarleton RL
    Res Immunol; 1991 Feb; 142(2):130-3. PubMed ID: 1678199
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.
    Minoprio P; Eisen H; Joskowicz M; Pereira P; Coutinho A
    J Immunol; 1987 Jul; 139(2):545-50. PubMed ID: 2955044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunopathology in experimental Chagas disease].
    González Cappa S
    Medicina (B Aires); 2000; 60(5 Pt 2):681-4. PubMed ID: 11188881
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity.
    Liew FY; Scott MT; Liu DS; Croft SL
    J Immunol; 1987 Oct; 139(7):2452-7. PubMed ID: 2958550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated immunity in mice innoculated with epimastigotes or trypomastigotes or Trypanosoma cruzi.
    Schmuñis GA; Vattuone H; Szarfman A; Pesce UJ
    Z Tropenmed Parasitol; 1973 Mar; 24(1):81-5. PubMed ID: 4200245
    [No Abstract]   [Full Text] [Related]  

  • 14. A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo.
    Spinella S; Milon G; Hontebeyrie-Joskowicz M
    Eur J Immunol; 1990 May; 20(5):1045-51. PubMed ID: 1972676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice.
    Tarleton RL; Scott DW
    Parasite Immunol; 1987 Sep; 9(5):579-89. PubMed ID: 2960943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Mycobacterium bovis BCG and cyclophosphamide.
    Abrahamsohn IA; Blotta MH; Curotto MA
    Infect Immun; 1981 Mar; 31(3):1145-51. PubMed ID: 6785239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.
    Kumar S; Tarleton RL
    J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD4+CD25+ T lymphocyte response time kinetics in patients with chronic Chagas disease after in vitro stimulation with recombinant Trypanosoma cruzi antigens.
    Braz SC; Lorena VM; Melo AS; Cavalcanti Mda G; Gomes Yde M
    Rev Soc Bras Med Trop; 2013; 46(3):362-6. PubMed ID: 23681433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
    Tarleton RL; Grusby MJ; Zhang L
    J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.